EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells

Ting La, Song Chen, Xiao Hong Zhao, Shuai Zhou, Ran Xu, Liu Teng, Yuan Yuan Zhang, Kaihong Ye, Liang Xu, Tao Guo, Muhammad Fairuz Jamaluddin, Yu Chen Feng und 10 weitere

Advanced Science · 2023

DOI: 10.1002/advs.202204599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Ting La und 21 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Institute, Henan Provincial and Zhengzhou City Key laboratory of Non-coding RNA and Cancer Metabolism, Henan International Joi…. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms, RNA, Long Noncoding, Cyclin-Dependent Kinase Inhibitor p27. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Excellent Youth Foundation of He'nan Scientific Committee, China; Hunter Medical Research Institute (T. La), Australia; the Cancer Council NSW.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

P53 inactivation occurs in about 50% of human cancers, where p53‐driven p21 activity is devoid and p27 becomes essential for the establishment of the G1/S checkpoint upon DNA damage. Here, this work shows that the E2F1‐responsive lncRNA LIMp27 selectively represses p27 expression and contributes to proliferation, tumorigenicity, and treatment resistance in p53‐defective colon adenocarcinoma (COAD) cells. LIMp27 competes with p27 mRNA for binding to cytoplasmically localized hnRNA0, which otherwise stabilizes p27 mRNA leading to cell cycle arrest at the G0/G1 phase. In response to DNA damage, LIMp27 is upregulated in both wild‐type and p53‐mutant COAD cells, whereas cytoplasmic hnRNPA0 is only increased in p53‐mutant COAD cells due to translocation from the nucleus. Moreover, high LIMp27 expression is associated with poor survival of p53‐mutant but not wild‐type p53 COAD patients. These results uncover an lncRNA mechanism that promotes p53‐defective cancer pathogenesis and suggest that LIMp27 may constitute a target for the treatment of such cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaColonic NeoplasmsRNA, Long NoncodingCyclin-Dependent Kinase Inhibitor p27HumansDNA DamageRNA, MessengerTumor Suppressor Protein p53

Stichwörter der Autor:innen

E2F1LIMp27colon cancerhnRNPA0lncRNAp27

Substanzen

RNA, Long NoncodingRNA, MessengerTumor Suppressor Protein p53CDKN1B protein, humanCyclin-Dependent Kinase Inhibitor p27

Autor:innen und Institutionen

  • Translational Research Institute, Henan Provincial and Zhengzhou City Key laboratory of Non-coding RNA and Cancer Metabolism, Henan International Join Laboratory of Non-coding RNA and Metabolism in Cancer, Henan Provinc…
  • Noncoding Cancer Biomarkers and Therapeutics Group, Cancer Detection & Therapy Research Program, Hunter Medical Research Institute, Callaghan, New South Wales, 2305, Australia.
  • School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, New South Wales, 2308, Australia.
  • National-Local Joint Engineering Research Center of Biodiagnosis & Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China.
  • Institute of Medicinal Biotechnology, Jiangsu College of Nursing, Huai'an, Jiangsu, 223300, China.
  • Institute of Future Agriculture, Northwest A&F University, Yangling, Shaanxi, 712100, China.

ORCID-Profile: Feng-Min Shao, Xu Dong Zhang, Lei Jin

Förderung

  • National Natural Science Foundation of China
  • Excellent Youth Foundation of He'nan Scientific Committee
  • China; Hunter Medical Research Institute (T. La), Australia; the Cancer Council NSW
  • Australia; the National Health and Medical Research Council

Zitieren

APA

La, T., Chen, S., Zhao, X. H., Zhou, S., Xu, R., Teng, L., Zhang, Y. Y., Ye, K., Xu, L., Guo, T., Jamaluddin, M. F., Feng, Y. C., Tang, H. J., Wang, Y., Xu, Q., Gu, Y., Cao, H., Liu, T., Thorne, R. F., …, & Jin, L. (2023). LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells. Advanced Science. https://doi.org/10.1002/advs.202204599

Vancouver

La T, Chen S, Zhao XH, Zhou S, Xu R, Teng L, et al. LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells. Advanced Science. 2023. doi:10.1002/advs.202204599

BibTeX
@article{La2023,
  author = {La, Ting and Chen, Song and Zhao, Xiao Hong and Zhou, Shuai and Xu, Ran and Teng, Liu and Zhang, Yuan Yuan and Ye, Kaihong and Xu, Liang and Guo, Tao and Jamaluddin, Muhammad Fairuz and Feng, Yu Chen and Tang, Hai Jie and Wang, Yanliang and Xu, Qin and Gu, Yue and Cao, Huixia and Liu, Tao and Thorne, Rick F and Shao, Feng-Min and Zhang, Xu Dong and Jin, Lei},
  title = {LncRNA LIMp27 Regulates the DNA Damage Response through p27 in p53‐Defective Cancer Cells},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202204599}
}
Kostenlos starten →